Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus?

被引：0
|
作者：
Afshin Salsali
Richard E Pratley
机构：
[1] A Salsali is an Assistant Professor of Medicine and RE Pratley is a Professor of Medicine and Director of the Diabetes and Metabolism Translational Medicine Unit,
[2] University of Vermont College of Medicine,undefined
[3] Burlington,undefined
[4] VT,undefined
[5] USA.,undefined
来源：
Nature Clinical Practice Endocrinology & Metabolism | 2007年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：450 / 451
页数：1
相关论文
共 50 条
  • [1] Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus? Commentary
    Salsali, Afshin
    Pratley, Richard E.
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (06): : 450 - 451
  • [2] Does addition of vildagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus?
    Retnakaran, Ravi
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (08): : 572 - 573
  • [3] Does addition of vildagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus?
    Ravi Retnakaran
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 572 - 573
  • [4] Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes
    Moses, R
    Slobodniuk, R
    Boyages, S
    Colagiuri, S
    Kidson, W
    Carter, J
    Donnelly, T
    Moffitt, F
    Hopkins, H
    [J]. DIABETES CARE, 1999, 22 (01) : 119 - 124
  • [5] The Addition of Sitagliptin to Metformin and Pioglitazone Therapy Enhances Glycemic Control in Patients with Type 2 Diabetes
    Fonseca, Vivian
    Staels, Bart
    Morgan, Jerry D., II
    Yue Shentu
    Golm, Gregory T.
    Johnson-Levonas, Amy O.
    Kaufman, Keith D.
    Goldstein, Barry J.
    Steinberg, Helmut
    Henry, Robert
    [J]. DIABETES, 2011, 60 : A308 - A308
  • [6] Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52weeks
    Kadowaki, Takashi
    Tajima, Naoko
    Odawara, Masato
    Nishii, Mikio
    Taniguchi, Tadaaki
    Ferreira, Juan Camilo Arjona
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (02) : 174 - 181
  • [7] EFFECTS OF COLESEVELAM, ROSIGLITAZONE, OR SITAGLIPTIN ON GLYCEMIC CONTROL AND LIPID PROFILE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY METFORMIN MONOTHERAPY
    Rigby, Scott. P.
    Handelsman, Yehuda
    Lai, Yu-Ling
    Abby, Stacey L.
    Tao, Ben
    Jones, Michael R.
    [J]. ENDOCRINE PRACTICE, 2010, 16 (01) : 53 - 63
  • [8] The addition of sitagliptin improves glycemic control in patients with type 2 diabetes
    不详
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 (12): : 790 - 790
  • [9] Does addition of pramlintide to basal insulin improve glycemic control in type 2 diabetes mellitus?
    Steven V Edelman
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 : 194 - 195
  • [10] Does addition of pramlintide to basal insulin improve glycemic control in type 2 diabetes mellitus?
    Edelman, Steven V.
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (04): : 194 - 195
12345